Antitrust M&A Strategic Path Re-Opened by the Amgen/Horizon Conduct Settlement
Client UpdatesAntitrust Update
Select Options
Thought Leadership
results
Page of
U.S. Supreme Court Affirmed Patent Enablement Requirement in Amgen
Client UpdatesIntellectual Property Update
Intellectual Property Report
Client UpdatesSpring Budget 2023: Chancellor Introduces Incentives for Tech Investments in the UK
Client UpdatesIntellectual Property Report
Client UpdatesFreedom to Operate Analysis Three Strategies to Efficiently Achieve Robust Results
Client UpdatesIntellectual Property Update
March-in Rights: Implications from the COVID-19 Pandemic
External ArticlePratt's Government Contracting Law Report
U.S. Supreme Court Grants Certiorari to Address Patent Enablement Requirement
Client UpdatesIntellectual Property Update
Intellectual Property Report
Client UpdatesNew Executive Order Details CFIUS National Security Factors
Client UpdatesInternational Trade Update
Intellectual Property Report
Client UpdatesIntellectual Property Report
Client UpdatesPre-Litigation Investigations and Due Diligence
External ArticlePre-ANDA Litigation: Strategies and Tactics for Developing a Drug Product and Patent Portfolio, 3rd Edition, Chapter 14, American Bar Association Book Publishing
Addressing Open Source Software Issues as Life Science Companies Embrace Hi-Tech Solutions
External ArticleIntellectual Property Report
Client Updates
Addressing Open Source Software Issues as Life Science Companies Embrace Hi-Tech Solutions
Client UpdatesIntellectual Property Report
Intellectual Property Report
Client UpdatesRetroactive Authorization of Sales and the Doctrine of Patent Exhaustion
Client UpdatesIntellectual Property Report
Federal Circuit Confirms ANDA Notice Letters Are Not Acts of Infringement for Venue Purposes
External ArticleNew York Law Journal, Volume 266, No. 99
Intellectual Property Report
Client UpdatesPandemic Patent Jury Trials Report: August 2020 - September 2021
Client UpdatesOn the Interface of Intellectual Property and Antitrust: The Case of Divisional Patent Applications in the Pharmaceutical Sector
Client UpdatesAntitrust Update
Intellectual Property Report
Client UpdatesU.S. Tax Court Clarifies the Tax Implications of Generic Drug Litigation
Client UpdatesTax Update
Intellectual Property Report
Client Updates
Masks Off: Navigating the COVID-19 Vaccine Era
Client UpdatesPrivacy and Data Security Update
Biden Administration First 100 Days Weekly Report - Episode 11
Client UpdatesWinter Storm Uri Consumer Resource Guide
Client UpdatesIntellectual Property Report
Client UpdatesAnimal-Based Medical Diagnostics: A Regulatory Problem
External ArticleFood and Drug Law Journal, Volume 75, Number 3
Considerations for a Biden Administration – Intellectual Property
VideoHow Will FDA Regulate Disease-Sniffing Dogs?
External ArticleFDLI Update Magazine
Advanced Biotechnology Claim Drafting Issues
Speeches & PresentationsSpeaker, Practicing Law Institute's Advanced Prosecution Workshop
Events
Recent
results
Page of
JP Morgan Healthcare Conference Private Reception
The U.S. Supreme Court's Impact on IP
Life Sciences 2021: The Road Ahead
A Conversation with Walter Isaacson: The Biotech Revolution and the Woman Who Launched It
In celebrating International Women's Day, Baker Botts is a proud sponsor, in partnership with the Chapter Network of The National Association of Corporate Directors, of the virtual conversation with Walter Isaacson and Dr. Helene Gayle, President & CEO of the Chicago Community Trust, on Monday, March 8, 2021 2:00 p.m. - 3:00 p.m. CT.
2020 JP Morgan Healthcare Conference Reception
Baker Botts and Salem Partners will be hosting a private reception during the J.P.Morgan Healthcare Conference to be held at Jasper's Corner Tap and Kitchen on Monday January 13, 2020.